I agree that this site is using cookies. You can find further informations here.
X
Vetter, Tatyana A.
44  results:
Search for persons X
?
1

C9ORF72 patient-derived endothelial cells drive blood-brain..:

Aragón-González, Ana ; Shaw, Allan C ; Kok, Jannigje R...
Fluids and Barriers of the CNS.  21 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Evaluation of safety and early efficacy of AAV gene therapy..:

Herstine, Jessica A. ; Chang, Pi-Kai ; Chornyy, Sergiy...
Molecular Therapy.  32 (2024)  6 - p. 1701-1720 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Dual FKRP/FST gene therapy in a single AAV normalizes ambul..:

Lam, Patricia ; Zygmunt, Deborah A. ; Ashbrook, Anna...
Molecular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Reduced cardiac antioxidant defenses mediate increased susc..:

Vetter, Tatyana A. ; Parthiban, Preethy ; Stevens, Jackie A....
Journal of Molecular and Cellular Cardiology.  190 (2024)  - p. 24-34 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Osteosarcoma tumors maintain intra-tumoral transcriptional ..:

Rajan, Sanjana ; Franz, Emily M. ; McAloney, Camille A....
BMC Biology.  21 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
6

CRISPR-Cas9 homology-independent targeted integration of ex..:

Stephenson, Anthony A. ; Nicolau, Stefan ; Vetter, Tatyana A....
Molecular Therapy - Methods & Clinical Development.  30 (2023)  - p. 486-499 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Persistence of exon 2 skipping and dystrophin expression at..:

Gushchina, Liubov V. ; Bradley, Adrienne J. ; Vetter, Tatyana A....
Molecular Therapy - Methods & Clinical Development.  31 (2023)  - p. 101144 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Host-derived growth factors drive ERK phosphorylation and M..:

McAloney, Camille A. ; Makkawi, Rawan ; Budhathoki, Yogesh...
Cellular Oncology.  47 (2023)  1 - p. 259-282 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Promising AAV.U7snRNAs vectors targeting DMPK improve DM1 h..:

Almeida, Camila F. ; Robriquet, Florence ; Vetter, Tatyana A....
Frontiers in Cell and Developmental Biology.  11 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
10

In-depth comparison of Anc80L65 and AAV9 retinal targeting ..:

Schwartz, Maura K. ; Likhite, Shibi ; Vetter, Tatyana A....
Molecular Therapy - Methods & Clinical Development.  30 (2023)  - p. 16-29 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Systemic PPMO-mediated dystrophin expression in the Dup2 mo..:

Gushchina, Liubov V. ; Vetter, Tatyana A. ; Frair, Emma C....
Molecular Therapy - Nucleic Acids.  30 (2022)  - p. 479-492 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Generation and characterization of a human induced pluripot..:

Lin, Hui ; Ye, Shi-Qiao ; Xu, Zhao-Hui...
Stem Cell Research.  65 (2022)  - p. 102958 , 2022
Link: https://doi.org/10.1016/..
 
?
13

A first-in-human phase I/IIa gene transfer clinical trial f..:

Flanigan, Kevin M. ; Vetter, Tatyana A. ; Simmons, Tabatha R....
Molecular Therapy - Methods & Clinical Development.  27 (2022)  - p. 47-60 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Systemic delivery of an AAV9 exon-skipping vector significa..:

Wein, Nicolas ; Vetter, Tatyana A. ; Vulin, Adeline...
Molecular Therapy - Methods & Clinical Development.  26 (2022)  - p. 279-293 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Pre-clinical dose-escalation studies establish a therapeuti..:

Simmons, Tabatha R. ; Vetter, Tatyana A. ; Huang, Nianyuan...
Molecular Therapy - Methods & Clinical Development.  21 (2021)  - p. 325-340 , 2021
Link: https://doi.org/10.1016/..
 
1-15